{"id":508452,"date":"2026-03-02T00:58:08","date_gmt":"2026-03-02T00:58:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/508452\/"},"modified":"2026-03-02T00:58:08","modified_gmt":"2026-03-02T00:58:08","slug":"drugs-like-ozempic-may-have-a-surprising-benefit-study","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/508452\/","title":{"rendered":"Drugs like Ozempic may have a surprising benefit: study"},"content":{"rendered":"<p>Talk about a surprise perk.<\/p>\n<p>Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, from improving cardiovascular health to <a href=\"https:\/\/nypost.com\/2025\/06\/24\/health\/weight-loss-drugs-like-ozempic-may-prevent-dementia-study\/\" rel=\"nofollow noopener\" target=\"_blank\">potentially preventing dementia<\/a> and lowering the <a href=\"https:\/\/nypost.com\/2025\/02\/28\/health\/studies-show-ozempic-can-lower-risk-of-depression\/\" rel=\"nofollow noopener\" target=\"_blank\">risk of depression<\/a>.<\/p>\n<p>Now, one more benefit could be added to the list, thanks to new research that found the blockbuster drugs could be a better treatment for one common ailment.<\/p>\n<p><img style=\"aspect-ratio:1.49926794;display:block\" loading=\"lazy\" decoding=\"async\" data-modal-image=\"38640469\" width=\"885\" height=\"590\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/03\/close-up-woman-injecting-semaglutide-117210718.jpg\" alt=\"Woman injecting semaglutide into her abdomen for diabetes or weight loss therapy.\" class=\"wp-image-38640469\"  \/>Numerous additional benefits of GLP-1 weight loss drugs have been discovered, including one for a common ailment. Lana Pietukhova \u2013 stock.adobe.com<\/p>\n<p>There are headaches, and then there\u2019s the kind of pain that more than 1 million people deal with worldwide \u2014 <a href=\"https:\/\/nypost.com\/2024\/09\/16\/health\/doctor-reveals-how-to-prevent-and-manage-headaches-migraine\/\" rel=\"nofollow noopener\" target=\"_blank\">migraines<\/a>.<\/p>\n<p>But a preliminary study has found an unexpected solution in glucagon-like peptide-1 receptor agonists for chronic migraines that could lead to fewer emergency room visits.<\/p>\n<p>The weight loss medications may even have better outcomes than Topamax (also known as <a href=\"https:\/\/my.clevelandclinic.org\/health\/drugs\/20648-topiramate-tablets\" target=\"_blank\" rel=\"noopener nofollow\">topiramate<\/a>), a common prescription medication for migraines and seizures.<\/p>\n<p>The findings, which will be presented at the <a href=\"https:\/\/www.aan.com\/events\/annual-meeting\" target=\"_blank\" rel=\"noopener nofollow\">2026 American Academy of Neurology\u2019s\u00a0Annual Meeting<\/a> in April, looked at two groups of about 11,000 people each who had a chronic migraine diagnosis based on medical records.<\/p>\n<p>One group started GLP-1 drugs for another condition, like type 2 diabetes, while the other started topiramate.<\/p>\n<p><img style=\"aspect-ratio:1.5585997;display:block\" loading=\"lazy\" decoding=\"async\" data-modal-image=\"38640470\" width=\"920\" height=\"590\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/03\/tired-business-woman-stress-works-116504000.jpg\" alt=\"A young woman experiencing a migraine attack while working on a laptop at home.\" class=\"wp-image-38640470\"  \/>An observational study found that those who suffer from migraines needed less emergency care while taking a GLP-1. Valerii Apetroaiei \u2013 stock.adobe.com<\/p>\n<p>Researchers found that people who started GLP-1 drugs were 10% less likely than those on topiramate to visit the ER over the course of a year.<\/p>\n<p>Those taking the weight loss drugs were also 14% less likely to be hospitalized for any reason.<\/p>\n<p>Those on the weight loss drugs were also less likely to start a new preventative migraine medication within the year.<\/p>\n<p>The researchers note, however, that the study was merely observational and only shows an association between the GLP-1s and less need for emergency care.<\/p>\n<p>\u201cChronic migraine often overlaps with metabolic and inflammatory conditions such as obesity, insulin resistance, sleep apnea and depression, which can make treatment more difficult,\u201d study author Vitoria Acar, of the University of Sao Paulo in Brazil, said in a <a href=\"https:\/\/www.eurekalert.org\/news-releases\/1118184?\" rel=\"nofollow noopener\" target=\"_blank\">press release<\/a>.<\/p>\n<p>While the findings are preliminary, the researchers think GLP-1s could help migraine patients in unexpected ways.<\/p>\n<p>\u201cEarly research is looking at whether GLP-1 drugs\u2019 anti-inflammatory and neurovascular effects could play a role in migraine treatment, not just through weight loss,\u201d Acar added.<\/p>\n<p>Although the groups were matched at the start of the study for age, body mass index, other health conditions and prior migraine treatments, the researchers were unable to measure factors that did change over the year, such as weight loss, migraine severity, use of medications and lifestyle changes.<\/p>\n<p>Further studies are needed to fully determine the effects of weight loss medications on migraine prevention and treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be&hellip;\n","protected":false},"author":2,"featured_media":508453,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,48,13663,84,202362,377,14592,953],"class_list":["post-508452","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-canada","tag-glp-1","tag-health","tag-medical-disorders","tag-medication","tag-study-says","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/508452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=508452"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/508452\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/508453"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=508452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=508452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=508452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}